scispace - formally typeset
M

Martin Dichgans

Researcher at Ludwig Maximilian University of Munich

Publications -  591
Citations -  63334

Martin Dichgans is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Stroke & CADASIL. The author has an hindex of 99, co-authored 523 publications receiving 48363 citations. Previous affiliations of Martin Dichgans include University of Edinburgh & Max Planck Society.

Papers
More filters
Journal ArticleDOI

The International Classification of Headache Disorders, 3rd edition (beta version)

Jes Olesen, +131 more
- 01 Jul 2013 - 
TL;DR: The International Classification of Headache Disorders, 3 edition (beta version), may be reproduced freely for scientific, educational or clinical uses by institutions, societies or individuals as mentioned in this paper. But the authors require the permission of the International Headache Society.
Journal ArticleDOI

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

TL;DR: This Position Paper summarises the main outcomes of this international effort to provide the STandards for ReportIng Vascular changes on nEuroimaging (STRIVE).
Journal ArticleDOI

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Denise Harold, +86 more
- 01 Oct 2009 - 
TL;DR: A two-stage genome-wide association study of Alzheimer's disease involving over 16,000 individuals, the most powerful AD GWAS to date, produced compelling evidence for association with Alzheimer's Disease in the combined dataset.
Journal ArticleDOI

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.

Paul Hollingworth, +177 more
- 01 May 2011 - 
TL;DR: Meta-analyses of all data provided compelling evidence that ABCA7 and the MS4A gene cluster are new Alzheimer's disease susceptibility loci and independent evidence for association for three loci reported by the ADGC, which, when combined, showed genome-wide significance.
Journal ArticleDOI

Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Valery L. Feigin, +416 more
- 03 Sep 2021 - 
TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) aims to provide a standardised and comprehensive measurement of these metrics at global, regional, and national levels.